A patient with obstructive jaundice due to bleeding in the common bile duct after ultrasound-guided liver biopsy

Muneki Igarashi1, Yoshihiro Tei, Fumiyuki Akino

  • 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Tokai School of Medicine, Bouseidai, Isehara, Kanagawa 259-1193, Japan. muneki@tokai-u.jp

Insights

A liver biopsy complication led to bleeding in the gallbladder and common bile duct, causing obstructive jaundice. Endoscopic retrograde cholangiopancreatography successfully removed the bile duct hematoma.

Area of Science:

  • Gastroenterology
  • Hepatology
  • Interventional Radiology

Background:

  • Chronic hepatitis C management often involves liver biopsy for staging and treatment guidance.
  • Ultrasound-guided liver biopsy is a common diagnostic procedure.
  • Complications, though rare, can occur following liver biopsy.

Observation:

  • A 63-year-old man undergoing interferon therapy for chronic hepatitis C developed acute right upper abdominal pain post-liver biopsy.
  • Emergency computed tomography (CT) revealed bleeding into the gallbladder and common bile duct.
  • The patient presented with obstructive jaundice attributed to a common bile duct hematoma.

Findings:

  • Endoscopic retrograde cholangiopancreatography (ERCP) confirmed a filling defect consistent with a hematoma in the common bile duct.
  • Endoscopic sphincterotomy was performed to facilitate hematoma removal.
  • Successful extraction of the bile duct hematoma was achieved.

Implications:

  • This case highlights a rare but serious complication of ultrasound-guided liver biopsy.
  • Prompt diagnosis and intervention using ERCP are crucial for managing post-biopsy biliary complications.
  • Effective management can prevent further morbidity associated with obstructive jaundice.

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...